About the Authors
- Marguerite M. Vantangoli
-
Affiliation Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, United States of America
- Samantha J. Madnick
-
Affiliation Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, United States of America
- Susan M. Huse
-
Affiliation Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, United States of America
- Paula Weston
-
Affiliation Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, United States of America
- Kim Boekelheide
-
* E-mail: Kim_Boekelheide@brown.edu
Affiliation Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, United States of America
Competing Interests
The authors of this manuscript have read the journal's policy and have the following competing interests: Author Kim Boekelheide is an occasional expert consultant for chemical and pharmaceutical companies, and owns stock in CytoSolv, an early stage biotechnology company developing a wound healing therapeutic. This study also received funding from Unilever. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MMV SJM KB. Performed the experiments: MMV SJM PW. Analyzed the data: MMV SJM SMH. Contributed reagents/materials/analysis tools: MMV SJM SMH PW KB. Wrote the paper: MMV SJM SMH PW KB.